Navigation Links
BRCA Mutations Don't Raise Breast Cancer Risk Equally
Date:1/8/2008

Study finds wide variation among families with carriers

TUESDAY, Jan. 8 (HealthDay News) -- Not all carriers of the BRCA1 and BRCA2 genetic mutations show the same risk for developing breast cancer.

In fact, a new study finds wide variation in risk among families carrying the mutations, indicating that the mutations are influenced by other genetic, and possibly environmental, factors.

"Risk among carriers varies considerably, and, if you accept that that's the case, there must be a reason why it varies, and the most plausible explanation is that there are other genetic factors affecting breast cancer risk that are being passed on through these families," said study author Colin Begg, chairman of the department of epidemiology and biostatistics at Memorial Sloan-Kettering Cancer Center in New York City.

And that's where more work needs to be done, said Begg, whose report was published in the Jan. 9/16 issue of the Journal of the American Medical Association.

"They're saying that not all BRCA mutations are created equal," added Dr. Len Lichtenfeld, deputy chief medical officer at the American Cancer Society.

It is known that the BRCA1 and BRCA2 gene mutations raise a woman's risk for developing breast cancer, so the degree of that risk is critical in helping a woman make choices about prevention.

But most previous studies have only looked at overall risk among mutation carriers, not individual risk or risk in specific groups.

"To some extent, people have traditionally perceived the risk as being a fixed thing," Begg said. "People have studied BRCA1 and 2 separately, but, other than that, there's the sense that if you're a carrier, you have a certain risk, and it's a high risk, and that's it."

Experts have hypothesized that there is variation in the risk of breast cancer in general due to other, as yet unknown, genetic factors, but there's scant evidence of su
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
2. Gene Mutations May Cause Rare Neonatal Diabetes
3. Survey confirms Americans prefer root canal treatment by endodontists
4. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
5. Treating your periodontal pockets may benefit your pocket book
6. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
7. Anxiety Raises Heart Attack Risk
8. High Levels of Stress After 9/11 Raised Heart Disease Risk
9. Lack of Deep Sleep Raises Diabetes Risk
10. High triglycerides, other cholesterol raise risk of stroke
11. Temporary Amnesia, Confusion Raise Stroke, Dementia Risk

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BRCA Mutations Don't Raise Breast Cancer Risk Equally
BRCA Mutations Don't Raise Breast Cancer Risk Equally
(Date:11/27/2009)... GSI Group Inc. (Pink She...n technology products and semiconductor systems, t...ny,s shareholders has been scheduled for Friday, A...ng will be announced in due course. As previously...ice from Stephen Bershad, a holder of greater than...
(Date:11/27/2009)...m Replikins Ltd. today issued its latest biochemic...ows that the lethality of the virus has dropped fr...urrent outbreak in the spring of 2009 to resting n...e H1N1 infectivity count, however, remains increas...mber 27, 2009 -- Biotech firm Replikins Ltd., whic...
(Date:11/27/2009)...Newswire-FirstCall/ -- The Gymboree Corporation (N...OO, will present at the NASDAQ OMX 23rd Investor P...n London, England, on Wednesday, December 2, 2009,...dcast of The Gymboree Corporation,s presentation o...m, click on "Our Company" at the bottom of the pag...
(Date:11/27/2009)...ce, Nov. 27 Team Garmin-Slipstream...icated to ethical sporting and developing the next...that it will become Team Garmin-Transitions with t...r of the team. Transitions Optical is the world,s ... the most advanced photochromic technology in the ...
(Date:11/27/2009)...ldings has announced that it has become a national...argest nonprofit organizations dedicated to arthri... Delray Beach, FL (Vocus) Novemb...O), a company specializing in the marketing and re... has announced today that is has become a national...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
...ide web foundation for the newly launched "indepen... Univita Health, a new company aimed at promoting...ndent aging, announced the acquisition of ENURGI, ... a virtual marketplace for individuals to find pro...
...fers quick-reference materials and multimedia tool...owing a child,s diagnosis , , BRIDGEWATER, N.J., ...ailability of the diabetes KidCare Kit, a multimed...st 30 days following a diagnosis of type 1 diabete...
...s the best way of spotting trouble, experts say , ...r versions of the stool-based colon cancer tests -...ry widely in their ability to spot potential abnor...e undetectable traces of blood that could come fro...
...Feb. 3 SuperGen, Inc. (Nasdaq: SUPG ), a pharma...velopment of novel cancer therapies, today announc...f Executive Officer, is scheduled to present at th...r Conference is scheduled to begin at 11:30 a.m. E...
...d Living Made Easy and Delicious with New Yoplait ... Probiotic Cultures , , MINNEAPOLIS, Feb. 3 Prob...th the latest flavor craze in the launch of Yoplai...men are familiar with probiotics, a strong indicat...
...Feb. 3 Alsius Corporation (Nasdaq: ALUS ), the ...gement (IVTM(TM)) therapies for critically ill pat...ond aggressively to the patent lawsuit brought aga...ement patents ZOLL purchased from a defunct compet...
Other Medicine News:Health News:Univita Health Acquires Leading Web Services Company 2Health News:New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes 2Health News:New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes 3Health News:New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes 4Health News:Stool-Based Colon Cancer Tests Vary Widely in Accuracy 2Health News:Stool-Based Colon Cancer Tests Vary Widely in Accuracy 3Health News:SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009 2Health News:Flavor and Function Are a Hot Match in 2009... Located In a Cool Place 2Health News:ALSIUS CORPORATION PREPARED TO INVALIDATE ZOLL TEMPERATURE MANAGEMENT PATENTS 2
(Date:11/29/2009)...ewswire/ -- FUJIFILM Medical Systems USA, Inc. is ...y flat panel DR cassette, at the 2009 Radiological...Ideal for any clinical environment, FDR D-EVO uses...s with Fujifilm,s trademark image quality and outs...for users to transition to DR without modification...
(Date:11/29/2009)...ewswire/ -- Stimulated by the ten years of Synapse... Systems USA announced today, at the Radiological ...e formation of its Medical Informatics Division ....up will integrate all functions associated with th...tform for future growth. ,, Several organizatio...
(Date:11/29/2009)...ewswire/ -- Researchers using functional magnetic ... have found that men and women respond differently...study presented today at the annual meeting of the..., "Men may direct more attention to sensory aspec...n terms of implications for required action, where...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 1New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 2New Jersey Dietetic Association Names Ketchums Jaime Schwartz Young Dietitian of the Year 52263 3Tips from the journals of the American Society for Microbiology 52258 1Tips from the journals of the American Society for Microbiology 52258 2Tips from the journals of the American Society for Microbiology 52258 3Tips from the journals of the American Society for Microbiology 52258 4Life on Earth came from other planets 9299 1Life on Earth came from other planets 9299 2Life on Earth came from other planets 9299 3Life on Earth came from other planets 9299 4
...to Explore the Efficacy of Novel Proteasome Inhibi...ry Multiple Myeloma, SOUTH SAN FRANCISCO, Calif. ...Research Consortium (MMRC) and Proteolix, Inc. tod...n a multi-center Phase 2,clinical trial to study P...or, carfilzomib (PR-171), in patients with relapse...
...nn., Aug. 15 Kevin McHale is,one of five board me..., a,non-profit organization incorporated in Saint ...sperson. HMH was created to gift cochlear implants... never be able to obtain one.,Dr. William House, t...its,on the Board of Directors., While the burden ...
Other Medicine Technology:The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4Kevin McHale Instrumental in Forming the 'Help Me Hear Foundation' 2
Thermal Transfer Wristbands
Patient-ID™
...I-MATCH III is a label-based patient ID system whi...ification System, an admitting band and up to six ...e only ID band worn by hospital patients. It integ...or blood banks into a multipurpose ID band that co...
Zebra H 2824-Z Healthcare Starter Kit
Medicine Products: